Ed Mathers

Edward Mathers has served on the board of directors since July 2017. Mr. Mathers has been a partner at New Enterprise Associates, Inc., a private venture capital firm, since August 2008. Mr. Mathers has served as a director of multiple publicly traded biopharmaceutical companies including ObsEva SA, since November 2015, Rhythm Pharmaceuticals Inc., since March 2013, Synlogic, Inc., since October 2012, Inozyme Pharma, Inc. since January 2017 and Mirum Pharmaceuticals, Inc. since November 2018. Mr. Mathers has also served on the board of directors at Akouos, Inc., a publicly traded biotechnology company, since October 2017. He previously served as a director of Liquidia Technologies, Inc., a publicly traded biopharmaceutical company, from April 2009 until May 2019, and as a director of Ra Pharmaceuticals, Inc., a publicly traded pharmaceutical company, from February 2010 until April 2020. He is also on the board of a number of private life sciences companies. Mr. Mathers earned his B.S. in chemistry from North Carolina State University.